Jones Edward Raymond 4
4 · Cytosorbents Corp · Filed Aug 20, 2020
Insider Transaction Report
Form 4
Jones Edward Raymond
Director
Transactions
- Exercise/Conversion
Common Stock
[F1]2020-08-18$3.35/sh+4,000$13,400→ 78,800 total - Exercise/Conversion
Stock Option (right to buy)
2020-08-18−4,000→ 0 totalExercise: $3.35From: 2020-12-31Exp: 2020-12-31→ Common Stock (4,000 underlying)
Footnotes (1)
- [F1]Includes: (i) the following RSUs that will be settled into common stock upon vesting upon a "Change In Control" of CytoSorbents Corporation (the "Company") as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 55,000 RSUs granted on April 8, 2015, (b) 5,000 RSUs granted on June 7, 2016, (c) 6,000 RSUs granted on February 24, 2017 and (d) 3,300 RSUs granted on March 15, 2018; and (ii) 9,500 shares of common stock owned by the reporting person.
Signature
/s/ Kathleen P. Bloch attorney-in-fact for Edward R. Jones|2020-08-20